HIGHLIGHTS
- who: Yasunari Matsuzaka and Ryu Yashiro from the (UNIVERSITY) have published the research: Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine, in the Journal: Vaccines 2023, 11, 569. of 29/01/2023
SUMMARY
Received Published: 1 March 2023 It has been reported that some mutant strains of the new coronavirus escape from neutralizing antibodies acquired by recoverees and vaccine recipients, in which the Omicron strain (B.1.1.529, BA strain) is resistant to therapeutic antibody formulations as well as neutralizing antibodies induced by two mRNA_vaccinations. MRNA_vaccines and viral_vector vaccines . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.